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Abstract – Direct and indirect economic costs related to 
chronic diseases are increasing in Europe due to the aging of 
population. One of the most challenging goals is to improve 
the quality of life of patients affected by chronic conditions, 
and enhance their self-management. In this paper, we 
propose a novel architecture of a scalable solution, based on 
mobile tools, aimed to keep patients with chronic diseases 
away from acute episodes, to improve their quality of life 
and, consequently, to reduce their economic impact. Our 
solution aims to provide patients with a personalized tool for 
improving self-management, and it supports both patients 
and clinicians in decision-making through the 
implementation of two different Decision Support Systems. 
Moreover, the proposed architecture takes into account the 
interoperability and, particularly, the compliance with data 
transfer protocols (e.g., BT4/LE, ANT+, ISO/IEEE 11073) 
to ensure integration with existing devices, and with the 
semantic web approaches and standards related to the 
content and structure of the information (e.g., HL7, ICD-10 
and openEHR) to ensure correct sharing of information 
with hospital information systems, and classification of 
patient behaviors (Coelition). The solution will be 
implemented and validated in future study. 
I. INTRODUCTION 
In the European region, the population aged 65 and 
over is projected to rise from 15% in 2000 to 23.5% by 
2030 [1]. This trend is considered as one of the reasons for 
the growing burden of chronic conditions and diseases. 
Chronic diseases, such as coronary heart disease, chronic 
respiratory diseases and diabetes, are the leading cause of 
mortality and morbidity in Europe [2]. The home 
environment and the informal caregivers are the most 
common care solution for chronic patients. The interaction 
among patients/caregivers and healthcare providers needs 
to be strengthened to enhance adherence to the clinical 
pathway and monitor health outcomes. 
Despite the increasing burden of chronic illnesses, 
healthcare is still largely built around an acute, episodic 
model of care that is ill-equipped to meet the requirements 
of those with chronic health problems [3]. Mobile 
technologies can support a healthcare redesign based on 
disease management programs and integrated care models 
[4], [5], [6], [7].  
Mobile technologies may act as a complementary tool 
to provide support and motivation to regular patient’s self-
monitoring of health parameters (e.g., blood pressure, 
heart rate, blood glucose) [8]. The resulting empowerment 
may help care recipients to achieve personal health 
objectives, modify lifestyle patterns and/or high-risk 
behaviors for an optimal management of their chronic 
condition.  
At present, over 35,000 mobile health (mHealth) apps 
are available for iOS and Android [9], but, despite the 
widespread diffusion, a lot of challenges are still to be 
faced, such as apps security, data safety, regulatory 
framework, interoperability, certification and quality, and 
integration in existing healthcare models [10], [11]. 
In the last decades, Decision Support Systems (DSSs), 
defined as any electronic or non-electronic system 
designed to aid directly in clinical decision making [12], 
gained increasing attention thanks to the promise to use 
characteristics of individual patients to generate patient-
specific assessments to support clinicians’ decision-
making.  
On the other hand, even though mobile technologies 
can ground the development of patients’ self-management 
systems, the development and use of DSSs for supporting 
patients’ decision-making is still lacking. 
In this paper, we preliminarily present the architecture 
of a comprehensive, mobile-based, patient-oriented 
solution aimed to diminish acute episodes of patients with 
chronic diseases in order to reduce their economic impact 
on the healthcare system and to improve their quality of 
life. These goals can be reached through the development 
of a new model of relation between patient and disease, 
based on a mobile technology that integrates Clinical DSS 
(CDSS) for physicians and Lifestyle DSS (LDSS) for 
patients. The model is primarily focused on self-
management of care, instead of handling the mere 
information exchange between patients and healthcare 
professionals. 
II. REQUIREMENTS 
Clinical physician-oriented DSSs are largely used and 
implemented while the new challenge is to create and 
integrate a patient-oriented DSS as an innovative tool 
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designed with the aim of providing patients with more 
knowledge about their conditions and the disease they are 
affected by, and guide them towards a healthy lifestyle. 
The majority of the mHealth existing solutions (e.g., 
glooko, bloodpressurecompanion, moticon, MetriaTM 
Wearable Sensor, nuubo®) provide acquisition and 
processing of pathology related to biomedical data and 
health status. However only few of them (e.g., mySugr, 
IndiGOTM) provide integration with clinical evidence and 
guidelines, and prediction of health status. 
The most common mHealth solution state-of-art 
limitations concern: 
 Lack of interoperability and scalability which also 
result in high initial costs for citizens [13]; 
 Lack of standards: many systems work only on 
proprietary platforms, from sensors to software 
(e.g., iPhone) and integrations with open platform 
such as Android are limited [14], [15]; 
 Cultural challenge: patients are unaccustomed to 
use technologies for clinical purposes, as they 
usually prefer to contact doctors directly [16]; 
 Need to improve mobile interface user-
friendliness and user experience [17]; 
 Need to increase the mutual information flow 
between healthcare professionals and patients 
rather than keeping with one direction flow of 
data from patients to clinicians [16]; 
 Need to guarantee privacy, integrity and 
confidentiality of the system information. 
The novelty of our proposal mainly concerns the 
requirements identified as key features of our system, that 
overcome the aforementioned limitations of the solutions 
currently available in the literature and market. 
Particularly, we defined the following requirements: 
 Open architecture; 
 Coexistence of clinical and lifestyle decision 
support systems; 
 Compliance to the existing standards and 
regulations; 
 Scalability and versatility of the system 
customizable to patients affected by different 
chronic diseases. 
III. ARCHITECTURE 
The proposed architecture is based on three layers (i.e., 
patient self-management, multiservice storage system and 
clinician supervision), as shown in Fig. 1. 
In order to allow the customization for different needs 
of different user groups (e.g., pathology, age) the use of 
loosely coupled set of heterogeneous modules were used. 
These modules are organized as apps, services and 
processes running either in foreground or background 
according to the specific implemented functionality. 
Regarding the scalability, our proposal is an architectural 
paradigm able to sustain a system designed to seamlessly 
handle changes and reconfigurations both in its front-end 
and in its back-end (Fig.1). Hence, introducing new 
sensors or apps in the input space or rules in the back-end 
that lead to new users’ functionalities (in the form of apps 
and tools) available at the output space, requires only 
minimal intervention. In order to comply with the privacy 
requirements, no sensitive clinical data are stored on the 
mobile device: personal, sensors and therapy information 
are stored in a remote DB that ensures privacy and 
provides a highly concentrated source of data, shared by 
all the mobile SW modules. Data integrity is foreseen 
through algorithms that can assure that authenticate users 
are handling unchanged and original information 
(cryptographic hash functions, such as Message Digest 5 
or Secure Hash Algorithm 1). To ensure confidentiality of 
data exchanged through the network from 
unauthorized/authorized agents, our solution is based on 
an encryption/decryption hybrid approach using 
symmetric and asymmetric algorithms to guarantee data 
confidentiality between the communication processes. 
The patient is engaged in the self-management starting 
from data acquisition using biomedical wireless sensors 
and also through input of self-reported data. 
 
 
Figure 1.  Overview of the proposed architecture 
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The collected data are processed firstly in the mobile 
device where they are validated, sent and, subsequently, 
stored in a central DB. The stored data (i.e., acquired new 
data, historical data, therapy, etc.) are extracted to feed a 
LDSS inference engine in order to provide feedback, 
recommendations and therapy reminders to the patient. 
Furthermore, interfaced with central DB, a CDSS provides 
a diagnostic and prognostic support to the clinician 
accessing the platform through a dedicated portal. The 
physician can directly alert the patient in emergency cases 
or change the prescribed therapy. 
The access to the central DB requires basic 
authentication, SSL channel and information 
cryptography. For the content and structure of the 
information semantic, web approaches and standards (e.g., 
HL7, ICD-10, and OpenEHR) are used to ensure correct 
sharing of information with hospital information system, 
and classification of patient behaviors (Coelition). 
The components of the architecture are briefly detailed 
in the following sessions. 
A. Patient Monitoring 
The first layer of the platform consists of a sensing 
device network which feeds the system with patient 
biomedical data needed for patient monitoring. 
Heterogeneous pathologies require different 
modalities/sensor types (e.g., weighing scale, blood 
pressure monitor). Consequently, the mobile application 
considers the compliance with transfer and data protocols 
(e.g., BT4/LE, ANT+, ISO/IEEE11073) to ensure 
integration with existing wearable devices. 
B. Patient Interface 
The patient interacts with the mobile application 
through its user-friendly interface, combining various 
input and output modalities (such as seeing/vision, 
hearing/audition, haptic/tactile). The main functionalities 
of the interface are: 
 displaying questions to the patient; 
 receiving feedback from the patient; 
 providing push messages (i.e., alerts, lifestyle 
suggestions, reminders, achieved goals); 
 enhance patients’ involvement, engagement and 
awareness through smart design and interaction, 
and social networking; 
 displaying biomedical parameters. 
C. LDSS: Patient’s Lifestyle DSS 
The LDSS correlates processed and validated data, 
coming from the central DB (from questionnaires, 
biomedical data, etc.) and lifestyle suggestions. This DSS 
provides patients only with recommendation related to 
healthy behaviors. It supports patients for staying away 
from acute episodes of their chronic condition through 
lifestyle suggestions.  
The core of LDSS is represented by an inference 
engine based on principles of probabilistic graphical 
models. For each specific condition addressed (e.g., 
Diabetes, Coronary Heart Disease CHD, Chronic 
Obstructive Pulmonary Disease COPD and Chronic 
Hypertension CHTN) a dedicated probabilistic model is 
implemented considering guidelines and existing 
predictive models. 
The LDSS uses information stored on the central DB 
in order to provide customized advices related to the 
management of the patient’s conditions. Particularly, the 
LDSS sends periodic advices concerning one or more of 
the following: 
 identification of undesired trends in 
measurements; 
 advice on healthy lifestyle including physical 
activities and suggested exercises; 
 dietary advice; 
 reminders regarding medications. 
The LDSS knowledge base is implemented using the 
Unified Medical Language System (UMLS) to represent 
concepts and relationships. 
D. Patient Middleware 
The previous modules are orchestrated around a 
middleware layer, conceived as a bus acting as the glue of 
the mutually interacting app(s), services and processes of 
the patient side architecture. The middleware offers all 
modules abstraction mechanisms to provide a generic 
API, suitable for the most common needs for customer 
extensions or third party apps and process integration, so 
that other mobile embeddable devices can be integrated 
directly onto the patient framework. Its main purpose is to 
direct and integrate processes and services. Table 1 shows 
the core capabilities provided by the middleware bus 
layers and it is also capable to proxy third party devices 
operative paradigms into our execution model for input 
data management and data conversion. 
E. Central DB 
The central DB is a database located in a separate and 
secure data center that provides a highly concentrated 
source of data and reports of randomized controlled 
patient’s lifestyle. Records contain the biomedical 
information and preferences of the patient collected by the 
LDSS and the related therapy and suggestions provided by 
the clinician through the CDSS.  
According to the Service-Oriented Architecture 
(SOA), the external database comes with a web service on 
server side in order to manage data flows with the central 
DB. An Input Data Manager Tool categorizes data in 
functional structures and stores them in the mobile DB of 
the device as RAW data. The latter are collected and 
processed by DSS in order to extract parameters and write 
them on the DB. Thus, the DB represents the source of 
data for all the tools integrated in middleware. 
One of the key features in the pre-processing stage is 
the pre-validation of the biomedical data: if the 
measurements are out of predetermined safe ranges, 
defined according to different and specific situations, the 
system asks the patient to repeat the measurement. 
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F. CDSS: Clinical DSS 
The CDSS provides automated advices to healthcare 
professionals by constantly monitoring and interpreting 
the patients’ data. This goal is achieved by using an 
intelligent diagnostic system based on existing 
probabilistic models (e.g., Archimedes [18], EAGLE [19], 
ADA guidelines [20], Seattle model [21], MAGGIC [22], 
ESC guidelines) that, according to the peculiarities of each 
patient, identifies trends and indicates possible undesired 
conditions or worsening of patient’s health. 
The CDSS provides advices intended for healthcare 
professionals. It is responsibility of the professional 
caregiver to interpret the output generated by the CDSS 
and decide whether to take further actions or ignore the 
alert provided by the CDSS. If the caregiver decides to 
take further actions, this is done by sending feedback (i.e., 
push messages) through the ICT network to the LDSS or 
contacting directly patients through SMS or phone calls. 
G. Clinician Interface 
The Clinician Interface foresees different User Profiles 
(Operators, Nurse, General Practitioner, and Specialist) 
that follow different rules in order to remotely monitor the 
patient by mean of several tools, such as: 
 Alarm Monitor 
 Electronic Health Record 
 Signal Visualization 
 Diagnostic Tools (advanced signal processing) 
 Notifications/Lifestyle Advice 
The Clinician Interface is developed in accordance to 
Medical Device Directive compliance. 
IV. DISCUSSION 
Here we proposed a novel architecture based on 
mHealth technologies for improving quality of life of 
patients affected by chronic conditions, and empowering 
their self-management. The architecture’s requirements 
are thought to overcome the main limitations of the 
solutions currently available in the literature and on the 
market. The modular architecture allows the technology to 
be customizable, scalable and applicable to different kinds 
of chronicity. The proposed architecture is based on the 
standards that guarantee interoperability with other 
medical devices and users’ privacy. Furthermore, the 
integration of two different Decision Support Systems, 
one dedicated to patients and one to clinicians, helps both 
patients and clinicians in decision-making for a better 
management of chronic condition oriented to decrease 
acute episodes. 
Our system may improve and enhance the 
communication and information flow between patients 
and medical professionals through the direct involvement 
of clinicians in case of need. 
However, in order to further boost patients’ wellbeing 
and engagement, the system may support both patients’ 
compliance with a good self-management and a positive 
mental status. Indeed, even though the DSS can improve 
the compliance of patients with their clinical pathway, an 
additional technique (i.e., gamification), could be added 
for strengthening the link between users and their good 
health. Moreover, an additional approach for enhancing a 
positive psychological status (i.e., mindfulness) should be 
taken into consideration in order to improve patients’ 
quality of life. 
The proposed solution will be implemented and 
validated in future work, also adding further features such 
as gamification and mindfulness. 
REFERENCES 
 
[1] J. Pomerleau, C. Knai , and E. Nolte, “The burden of chronic 
disease in Europe,” in Caring for people with chronic disease. A 
health system perspective, E. Nolte and M. McKee, Eds. 
Maidenhead: McGraw-Hill Education, 2008, pp. 15-42. 
[2] R. Busse R, Tackling chronic disease in Europe: strategies, 
interventions and challenges, No. 20, WHO Regional Office 
Europe, 2010. 
[3] M. M. Harbers and P. W. Achterberg, Europeans of retirement 
age: chronic diseases and economic activity, Bilthoven: RIVM, 
2012. 
[4] R. Istepanian , S. Laxminarayan, and C. S. Pattichis “Introduction 
to mobile m-health systems,” in M-health: Emerging Mobile 
Health Systems, Springer, Berlin Heidelberg, 2006, p. 3. 
TABLE I.  CORE CAPABILITIES OF MIDDLEWARE LAYER 
Capability Description 
Invocation 
support for synchronous and asynchronous 
communication protocols, service mapping 
(locating and binding) 




adapters, protocol transformation, service 
mapping, as we are expecting to integrate 
different components, with likely different 
origins and thus semantics 
Messaging message processing, message transformation and message enhancement 
Process  
choreography implementation of complex business processes 
Service  
orchestration 
coordination of multiple implementation services 
exposed as a single, aggregate service 
Complex event 
processing 




security (encryption and signing), reliable 
delivery, transaction management 
Management monitoring, audit, logging, metering, admin console 
Protocol  
Conversion 
comprehensive support for topical 
communication protocols service standards 
Security a standardized security model to authorize, authenticate and audit use of the ESB 
Transformation 
facilitation of the transformation of data formats 
and values, including transformation services 
(often via XSLT or Query) between the formats 
of the sending application and the receiving 
application 
Validation validation against schemas for sending and receiving messages 
Abstraction the provision of a unified abstraction across multiple layers 
Routing and 
Transformation 
routing or transforming messages conditionally, 
based on a non-centralized policy (without the 
need for a central rules engine) 
Queuing and 
staging 
queuing, holding messages if 
applications/network connections temporarily 
become unavailable or work at different speeds 
Commodity 
Services 
provisioning of commonly used functionality as 
shared services depending on context 
722 MIPRO 2016/CTI
[5] M. Kay , J. Santos, and M. Takane mHealth: New horizons for 
health through mobile technologies, World Health Organization, 
2011, pp. 66-71. 
[6] R. Luanrattana, K. T. Win, J. Fulcher, and D. Iverson, “Mobile 
Technology Use in Medical Education,” Journal of Medical 
Systems, vol. 36, pp. 113-122, 2012. 
[7] Y. SC, “Mobile applications and 4G wireless networks: A 
framework for analysis,” Campus-Wide Information Systems, vol. 
29, pp. 344-357, 2012. 
[8] S. Marceglia, S. Bonacina, V. Zaccaria, C. Pagliari, and F. 
Pinciroli, “How might the iPad change healthcare?,” J R Soc Med, 
vol. 105, pp. 233-41, 2012. 
[9] A. Sunyaev, T. Dehling, P. L. Taylor, and K. D. Mandl, 
“Availability and quality of mobile health app privacy policies,” 
Journal of the American Medical Informatics Association, 
amiajnl-2013, 2014. 
[10] The PLOS Medicine Editors, “A reality checkpoint for mobile 
health: three challenges to overcome,” PLoS Med, vol. 10, 
e1001395, 2013. 
[11] P. Quinn, A.K. Habbig, E. Mantovani, and P. De Hert, “The data 
protection and medical device frameworks-obstacles to the 
deployment of mHealth across Europe?,” European journal of 
health law, vol. 20, pp. 185-204, 2013. 
[12] K. Kawamoto, C. A. Houlihan, E. A. Balas, and D. F. Lobach, 
“Improving clinical practice using clinical decision support 
systems: a systematic review of trials to identify features critical to 
success,” Bmj, vol 330, pp. 765, 2005. 
[13] Mobile Health Alliance (2013) at http://mhealthalliance.org. 
[14] D. Lou, X. Chen, Z. Zhao,Y. Xuan, Z. Xu, H. Jin, et al., “A 
Wireless Health Monitoring System based on Android Operating 
System,” IERI Procedia, vol. 4, pp. 208-215, 2013. 
[15] B. Martínez-Pérez, I. De la Torre-Díez, and M. López-Coronado, 
“Mobile Health Applications for the Most Prevalent Conditions by 
the World Health Organization: Review and Analysis,” Journal of 
medical Internet research, vol 15, e120, 2013. 
[16] R. Elangovan, and S. Arulchelvan, “A study on the role of mobile 
phone communication in tuberculosis DOTS treatment,” Indian 
journal of community medicine, vol. 38, pp. 229-233, 2013. 
[17] O.Vélez, P. Okyere, S. A. Kanter, and S. Bakken, “A usability 
study of a mobile health application for rural Ghanaian 
Midwives,” Journal of Midwifery & Women’s Health, vol. 59, pp. 
184-191, 2014. 
[18] D. M. Eddy, and L. Schlessinger, “Archimedes: a trial-validated 
model of diabetes,” Diabetes Care, vol. 26, pp. 3093-3101, 2003. 
[19] E. Mueller, S. Maxion-Bergemann, D. Gultyaev, S. Walzer, N. 
Freemantle, C. Mathieu, et al., “Development and validation of the 
Economic Assessment of Glycemic Control and Long-Term 
Effects of diabetes (EAGLE) model,” Diabetes technology & 
therapeutics, vol. 8, pp. 219-236, 2006. 
[20] American Diabetes Association, “Standards of medical care in 
diabetes-2016 Abridged for primary care providers,” Clinical 
Diabetes, vol. 34, pp. 3-21, 2016. 
[21] W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. 
Anker, A.B. Cropp, et al., “The seattle heart failure model: 
Prediction of survival in heart failure,” Circulation, vol. 113, pp. 
1424-1433, 2006. 
[22] S.J. Pocock, C.A. Ariti, J.J. McMurray, A. Maggioni, L. Køber, 
I.B. Squire, et al., “Predicting survival in heart failure: a risk score 
based on 39372 patients from 30 studies,” European heart journal, 
ehs337, 2012. 
 
 
MIPRO 2016/CTI 723
